The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis
<p>Abstract</p> <p>Background</p> <p>Among the most harmful of all genetic abnormalities that appear in colorectal cancer (CRC) development are mutations of KRAS and its downstream effector BRAF as they result in abnormal extracellular signal-related kinase (ERK) signal...
Main Authors: | Boucher Marie-Josée, Lussier Jacques G, Carrier Julie C, Cagnol Sébastien, Durand Véronique, Lemieux Etienne, Bergeron Sébastien, Rivard Nathalie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/271 |
Similar Items
-
Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms
by: Jordan R. Yaron, et al.
Published: (2021-03-01) -
Fasciola hepatica serine protease inhibitor family (serpins): Purposely crafted for regulating host proteases.
by: Carolina De Marco Verissimo, et al.
Published: (2020-08-01) -
Contrôle de la mort cellulaire par la voie des MAPK1/3 (ERK2/1)
by: Cagnol, Sébastien
Published: (2005) -
Species-Specific Serological Detection for Schistosomiasis by Serine Protease Inhibitor (SERPIN) in Multiplex Assay.
by: Chihiro Tanigawa, et al.
Published: (2015-01-01) -
Carbohydrate-controlled serine protease inhibitor (serpin) production in Bifidobacterium longum subsp. longum
by: S. Duboux, et al.
Published: (2021-03-01)